The Focal Segmental Glomerulosclerosis Treatment market is experiencing demand from hospitals, nephrology clinics, specialty centers, and transplant facilities. These institutions provide diagnosis, medication management, dialysis, and long-term kidney care. The focal segmental glomerulosclerosis (FSGS) treatment market was valued at US$ 2.39 billion in 2025 and is expected to reach US$ 3.98...